Commitment and differentiation of stem cells to the osteoclast lineage

Biochemistry and Cell Biology

Volumn 76, Issue 6, 1998, Pages 911-922

  Hayashi, Shin Ichi ^a   Yamane, Toshiyuki ^a   Miyamoto, Akitomo ^a,b   Hemmi, Hiroaki ^a   Tagaya, Hisashi ^a   Tanio, Yasuko ^a,c   Kanda, Hidenobu ^a,d   Yamazaki, Hidetoshi ^a   Kunisada, Takahiro ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Sansho Seiyaku Co Ltd   (Japan)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Hematopoiesis; M CSF; ODF OPGL; Osteoclast; Osteopetrosis; Stem cell

Indexed keywords

COLONY STIMULATING FACTOR 1; GROWTH FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ALBERS SCHOENBERG DISEASE; BONE REMODELING; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYO DEVELOPMENT; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHYLOGENY; REVIEW;

ANIMALIA;

EID: 0032323347     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o98-099     Document Type: Review

References (125)

1. 3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc. Natl. Acad. Sci. U.S.A. 80: 5583-5587.
2. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood, 88: 4029-4039.
3. Akatsu, T., Takahashi, N., Debari, K., Morita, I., Murota, S., Nagata, N., Moseley, J.M., Martin, T.J., and Suda, T. 1989a. Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′, 5′-monophosphate in mouse bone marrow cell cultures. J. Bone Miner. Res. 4: 29-35.
4. Akatsu, T., Takahashi, N., Udagawa, N., Sata, K., Nagata, N., Moseley, J.M., Martin, T.J., and Suda, T. 1989b. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. Endocrinology (Baltimore), 125: 20-27.
5. Akatsu, T., Takahashi, N., Udagawa,N., Imamura, K., Yamaguchi, A., Sato, K., Nagata, N., and Suda, T. 1991. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Miner. Res. 6: 183-190.
6. Allan, E.H., Hilton, D.J., Brown, M.A., Evely, R.S., Yumita, S., Metcalf, D., Gough, N.M., Ng, K.W., Nicola, N., and Martin, T.J. 1990. Osteoblasts display receptors for and responses to leukemia-inhibitory factor. J. Cell. Physiol. 145: 110-119.
7. Anderson, D.A., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (London), 390: 175-179.
8. Ash, P., Loutit, J.F., and Townsend, K.M.S. 1980. Osteoclasts derived from haematopoietic stem cells. Nature (London), 283: 669-670.
9. Athanasou, N.A., and Quinn, J. 1990. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J. Clin. Pathol. 43: 997-1003.
10. Begg, S.K., Radley, J.M., Pollard, J.W., Chisholm, O.T., Stanley, E.R., and Bertoncello, I. 1993. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177: 237-242.
11. Bloom, W., and Fawcett, D.W. 1986. A textbook of histology. 11th ed. W.B. Saunders Company, Philadelphia.
12. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90: 1622-1627.
13. Bucay, N., Sarosi, I., Dunstan, C.R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H.L., Xu, W., Lacey, D.L., Boyle, W.J., and Simonet, W.S. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12: 1260-1268.
14. btsA58 transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 90: 5578-5582.
15. Colbert, E.H., and Morales, M. 1991. Evolution of the vertebrates. 4th ed. Wiley-Liss, Inc., N.Y.
16. Dubreuil, P., Forrester, L., Rottapel, R., Reedijk, M., Fujita, J., and Bernstein, A. 1991. The c-fms gene complements the mitogenic defect in mast cells derived from mutant W mice but not mi (microphthalmia) mice. Proc. Natl. Acad. Sci. U.S.A. 88: 2341-2345.
17. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E., and Derynck, R. 1995. Toward a molecular understanding of skeletal development. Cell, 80: 371-378.
18. Fawcett, D.W. 1942. The amedullary bones of the Florida manatee. Am. J. Anat. 71: 271-309.
19. Felix, R., Cecchini, M.G., and Fleisch, H. 1990. Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology (Baltimore), 127: 2592-2594.
20. Franzoso, G., Carlson, L., Xing, L. Poljak, L., Shores, E.W., Brown, K.D., Leonardi, A., Tran, T., Boyce, B.F., and Siebenlist, U. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11: 3482-3496.
21. Galli, S.J., Zsebo, K.M., and Geissler, E.N. 1993. The kit ligand, stem cell factor. Adv. Immunol. 55: 1-96.
22. Girasole, G., Passeri, G., Jilka, R.L., and Manolagas, S.C. 1994. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest. 93: 1516-1524.
23. Goto, M. 1993. Origin and evolution of skeletal tissues in vertebrates. In Structure, formation and evolution of fossil hard tissues. Edited by I. Kobayashi, H. Mutvei, and A. Sahni. Tokay University Press, Tokyo, Japan. pp. 101-106.
24. Greenfield, E.S., Gornik, S.A., Horowitz, M.C., Donahue, H.J., and Shaw, S.M. 1993. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J. Bone Miner. Res. 3: 1163-1171.
25. Gruneberg, H. 1936. Grey-lethal, a new mutation in the house mouse. J. Hered. 27: 105-109.
26. Grigoriadis, A.E., Wang, Z.-Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A., and Wagner, E.F. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (Washington, D.C.), 266: 443-448.
27. Hagenaars, C.E., van der Kraan, A.A.M., Kawilarang de Haas, E.W.M., Visser, J.W.M., and Nijweide, P.J. 1989. Osteoclast formation from cloned pluripotent hematopoietic stem cells. Bone Miner. 6: 179-189.
28. Hagenaars, C.E., Kawilarang-de Haas, E.W.M., van der Kraan, A.A.M., Spooncer, E., Dexter, T.M., and Nijweide, P.J. 1991. Interleukin-3-dependent hematopoietic stem cell lines capable of osteoclast formation in vitro. J. Bone Miner. Res. 6: 947-954.
29. Hallberg, B., Thomell, A., Holm, M., and Grundstrom, T. 1992. SEF1 binding is important for T cell specific enhancer of genes for T cell receptor-CD3 subunits. Nucleic Acids Res. 20: 6495-6499.
30. Halstead, L.B. 1974. Vertebrate hard tissues. Wykeham Publications Ltd., London.
31. Hattersley, G., and Chambers, T.J. 1989. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J. Cell. Physiol. 140: 478-482.
32. Hattersley, G., Kerby, J.A., and Chambers, T.J. 1991. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology (Baltimore), 128: 259-262.
33. Hayashi, S.I., Miyamoto, A., Yamane, T., Kataoka, H., Ogawa, M., Sugawara, S., Nishikawa, S., Nishikawa, S.I., Sudo, T., Yamazaki, H., and Kunisada, T. 1997. Osteoclast precursors in bone marrow and peritoneal cavity. J. Cell. Physiol. 170: 241-247.
34. Hayman, A.R., Warburton, M.J., Pringle, J.A.S., Coles, B., and Chambers, T.J. 1989. Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastoma. Biochem. J. 261: 601-609.
35. Hayman, A.R., Jones, S.J., Boyde, A., Foster, D., Colledge, W.H., Carlton, M.B., Evans, M.J., and Cox, T.M. 1996. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development (Cambridge), 122: 3151-3162.
36. Hemesath, T.J., Steingrimsson, E., McGill, G., Hansen, M.J., Vaught, J., Hodgkinson, C.A., Arnheiter, H., Copeland, N.G., Jenkins, N.A., and Fisher, D.E. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8: 2770-2780.
37. Hemesath, T.J., Price, E.R., Takemoto, C., Badalian, T., and Fisher, D.E. 1998. MAP kinase links the transcription factor microphthalmia to c-Kit signalling in melanocytes. Nature (London), 391: 298-301.
38. Hentunen, T.A., Reddy, S.V., Boyce, B.F., Devlin, R., Park, H.R., Chung, H., Selander, K.S., Dallas, M., Kurihara, N., Galson, D.L., Goldring, S.R., Koop, B.A., Windle, J.J., and Roodman, G.D. 1998. Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage intransgenic mice. J. Clin. Invest. 102: 88-97.
39. Hodgkinson, C.A., Moore, K.J., Nakayama, A., Steingrimsson, E., Copeland, N.G., Jenkins, N.A., and Arnheiter, H. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell, 74: 395-404.
40. Hofstetter, W., Wetterwald, A., Cecchini, M.C., Felix, R., Fleisch, H., and Mueller, C. 1992. Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc. Natl. Acad. Sci. U.S.A. 89: 9637-9641.
41. Horton, J.D. 1994. Amphibians. In Immunology: a comparative approach. Edited by R.J. Turner. John Wiley & Sons, Chichester, West Sussex, U.K. pp. 69-100.
42. Horton, J.D., and Ratcliffe, N. 1996. Evolution of immunology. In Immunology. 4th ed. Edited by I. Roitt, J. Brostoff, and D. Male. London. pp. 15.1-15.22.
43. Iotsova, V., Caamano, J., Loy, J. Yang, Y., Lewin, A., and Bravo, R. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3: 1285-1289.
44. Jee, W.S.S., and Nolan, P.D. 1963. Origin of osteoclasts from the fusion of phagocytes. Nature (London), 200: 225-226.
45. Jimi, E., Ikebe, T., Takahashi, N., Hirata, M., Suda, T., and Koga, T. 1996. Interleukin-1a activates an NF-kB-like factor in osteoclast-like cells. J. Biol. Chem. 271: 4605-4608.
46. 3 tissue-specifically regulates in vivo production of the third component of complement (C3) in bone. Endocrinology (Baltimore), 131: 2468-2475.
47. Johnson, R.S., Spiegelman, B.M., and Papaioannou, V. 1992. Pleiotropic effects of a null mutation in the c-fos protooncogene. Cell, 71: 577-586.
48. Kahn, A.J., and Simmons, D.J. 1975: Investigation of cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature (London), 258: 325-327.
49. Kamachi, Y., Ogawa, E., Asano, M., Ishida, S., Murakami, Y., Satake, M., Ito, Y., and Shigesada, K. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64: 4808-4819.
50. Kawasaki, E.S., Ladner, M.B., Wang, A.M., Van Arsdell, J., Warren, M.K., Coyne, M.Y., Schweickart, V.L., Lee, M.T., Wilson, K.J., Boosman, A., Stanley, E.R., and Mark, D.F. 1985. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). (Washington, D.C.), 230: 291-296.
51. Kitamura, Y. 1989. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7: 59-76.
52. Kiyokawa, T., Yamaguchi, K., Takeya, K., Takahashi, K., Watanabe, T., Matsumoto, T., Lee, S.U., and Takatsuki, K. 1986. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia. Cancer 59: 1187-1191.
53. Kodama, H., Yamasaki, A., Nose, M., Niida, S., Ohgame, Y., Abe, M., Kumegawa, M., and Suda, T. 1991. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J. Exp. Med. 173: 269-272.
54. Kodama, H., Nose, M., Niida, S., Nishikawa, S., and Nishikawa, S.I. 1994. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp. Hematol. 22: 979-984.
55. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.-H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, Y., and Kishimoto, T. 1997. Target disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89: 755-764.
56. Kurihara, N., Suda, T., Miura, Y., Nakauchi, H., Kodama, H., Hiura, K., Hakeda, Y., and Kumegawa, M. 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood, 74: 1295-1302.
57. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H, Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W,J. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93: 165-176.
58. Lagasse, E., and Weissman, I.L. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell, 89: 1021-1031.
59. Lee, T.H., Fevold, K.L., Muguruma, Y., Lottsfeldt, J.L., and Lee, M.Y. 1994. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development. Exp. Hematol. 22: 66-73.
60. Maecker, H.T., Todd, S.C., and Levy, S. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11: 428-442.
61. Manning, M.J. 1994. Fishes. In Immunology: a comparative approach. Edited by R.J. Turner. John Wiley & Sons, Chichester, West Sussex, U.K. pp. 69-100.
62. Miyamoto, A., Kunisada, T., Hemmi, H., Yamane, T., Yasuda, H., Miyake, K., Yamazaki, H., and Hayashi, S.I. 1998. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem. Biophys. Res. Commun. 242: 703-709.
63. Moore, K.J. 1995. Insight into the microphthalmia gene. Trends Genet. 11: 442-448.
64. Morii, E., Takebayashi, K., Motohashi, H., Yamamoto, M., Nomura, S., and Kitamura, Y. 1994. Loss of DNA binding ability of the transcription factor encoded by the mutant mi locus. Biochem. Biophys. Res. Commun. 205: 1299-1304.
65. Muguruma, Y., and Lee, M.Y. 1998. Isolation and characterization of murine clonogenic osteoclast progenitors by cell surface phenotype analysis. Blood, 91: 1272-1279.
66. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, A., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H.M., Owen, M.J., Mertelsmann, R., Zabel, B.U., and Olsen, B.R. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89: 773-779.
67. Mundy, G.R., and Roodman, G.D. 1987. Osteoclast ontogeny and function. Bone Miner. Res., 5: 209-279.
68. Nishikawa, S.I., Ogawa, M., Nishikawa, S., Kunisada, T., and Kodama, H. 1988. B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur. J. Immunol. 18: 1767-1771.
69. Oritani, K., Wu, X., Medina, K., Hudson, J., Miyake, K., Gimble, J.M., Burstein, S.A., and Kincade, P.W. 1996. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood, 87: 2252-2261.
70. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W.H., Beddington, R.S.P., Mundlos, S., Olsen, B.R., Selby, P.B., and Owen, M.J. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 89: 765-771.
71. Oursler, M.J., Osdoby, P., Pyfferoen, J., Roggs, B.L., and Spelsberg, T.C. 1991. Avian osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. U.S.A. 88: 6613-6617.
72. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, FW., and Orkin, S.H. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell, 86: 47-57.
73. Rajavashistha, T.B., Eng, R., Shadduck, R.K., Waheed, A., Ben-Avram, C.M., Shively, J.E., and Lusis, A.J. 1987. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc. Natl. Acad. Sci. U.S.A. 84: 1157-1161.
74. Romer, A.S., and Parsons, T.S. 1977. The vertebrate body. 5th ed. W.B. Saunders, Philadelphia.
75. Russell, E.S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20: 357-458.
76. Scheven, B.A.A., Visser, J.W.M., and Nijweide, P.J. 1986. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature (London), 321: 79-81.
77. Schneider, G.B. 1985. Cellular specificity of the cure for osteopetrosis: isolation of and treatment with pluripotent hemopoietic stem cells. Bone, 6: 241-247.
78. Seifert, M.F., and Mark, Jr., S.C. 1985. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am. J. Anat. 172: 141-153.
79. Sherr, C.J. 1990. Colony-stimulating factor-1 receptor. Blood, 75: 1-12.
80. Shevde, N., Anklesaria, P., Greenberger, J.S., Bleiberg, I., Glowacki, J. 1994. Stromal cell-mediated stimulation of osteoclastogenesis. Proc. Soc. Exp. Biol. Med. 205: 306-315.
81. Shin, J.H., Kukita, A., Ohki, K., Katsuki, T., and Kohashi, O. 1995. In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells. Endocrinology (Baltimore), 136: 4285-4292.
82. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., and Boyle, W.J. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89: 309-319.
83. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 64: 693-702.
84. Stanley, E.R., and Heard, P.M. 1977. Factors regulating macrophage production and growth: purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J. Biol. Chem. 252: 4305-4312.
85. Steingrimsson, E., Moore, K.J., Lamoreux, M.L., Ferre-D'Amare, A.R., Burley, S.K., Sanders-Zimring, D.C., Skow, L.C., Hodgkinson, C.A., Arnheiter,H., Copeland, N.G., and Jenkins, N.A. 1994. Molecular basis of microphthalamia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8: 256-263.
86. Steingrimsson, E., Nii, A., Fisher, D.E., Ferre-D'Amare, A.R., McCormick, R.J., Russell, L.B., Burley, S.K., Ward, J.M., Jenkins, N.A., and Copeland, N.G. 1996. The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J. 15: 6280-6289.
87. Suda, T. 1998. Lessons from the space experiment SL-J/FMPT/L7: Tthe effect of microgravity on chicken embryogenesis and bone formation. Bone, 22: 73S-78S.
88. Suda, T., Takahashi, N., and Martin, T.J. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13: 251-265.
89. Suda, T., Udagawa, N., and Takahashi, N. 1996. Cells of bone: osteoclast generation. In Principles of bone biology. Edited by J.P. Bilezikian, L.G. Raisz, and G.A. Roden. Academic Press Inc., New York. pp. 87-102.
90. Sudo, T., Nishikawa, S., Ogawa, M., Kataoka, H., Ohno, N., Izawa, A., Hayashi, S.I., and Nishikawa, S.I. 1995. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene, 11: 2469-2476.
91. Taga, T., and Kishimoto, T. 1997. gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15: 797-819.
92. Takahashi, N., Akatsu, T., Sasaki, T., Nicholson, G.C., Moseley, J.M., Martin, T.J., and Suda, T. 1988a. Induction of calcitonin receptors by 1α,25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology (Baltimore), 123: 1504-1510.
93. Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G.D., Mundy, G.R., Jones, S.J., Boyde, A., and Suda, T. 1988b. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology (Baltimore), 122: 1373-1382.
94. Takahashi, N., Udagawa, N., Tanaka, S., Murakami, H., Owan, I., Tamura, T., and Suda, T. 1994. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev. Biol. 163: 212-221.
95. Takebayashi, K.,Chida, K., Tsukamoto, I., Morii, E., Munakata, H., Arnheiter, H., Kuroki, T., Kitamura, Y., and Nomura, S. 1996. The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential. Mol. Cell. Biol. 16: 1203-1211.
96. Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., Taga, T., Kishimoto, T., and Suda, T. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 90: 11 924-11 928.
97. Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E.R., Kurokawa, T., and Suda, T. 1993. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91: 257-263.
98. Tanaka, S., Amling, M., Neff, L., Peyman, A., Uhlmann, E., Levy, J.B., and Baron, R. 1996. c-Cb1 is downstream of c-Src in a signalling pathway neccessary for bone resorption. Nature (London), 383: 528-531.
99. Tanio, Y., Yamazaki, H., Kunisada, T., and Hayashi, S.I. 1999. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis. Exp. Hematol. In press.
100. Thesingh, C.W. 1986. Formation sites and distribution of osteoclast progenitor cells during the ontogeny of the mouse. Dev. Biol. 117: 127-134.
101. Tondravi, M.M., McKercher, S.R., Anderson, K., Erdmann, J.M., Quiroz, M., Maki, R., and Teitelbaum, S.L. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature (London), 386: 81-84.
102. Turner, R.J. 1994. Immunology: a comparative approach. Edited by R.J. Turner. John Wiley & Sons, Chichester, West Sussex, U.K.
103. Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., Kodama, H., Martin, T.J., and Suda, T. 1989. The bone marrow-derived stromal cell line MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (Baltimore), 125: 1805-1813.
104. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T.J., and Suda, T. 1990. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. U.S.A. 87: 7260-7264.
105. Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findley, D.M., Martin, T.J., Hirota, H., Taga, T., Kishimoto, T., and Suda, T. 1995. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182: 1461-1468.
106. Udagawa, N., Horwood, N.J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T.J., Martin, T.J., and Gillespie, M.T. 1997. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte macrophage-colony stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J. Exp. Med. 185: 1005-1012.
107. Van Beek, E., Van der Wee-Pals, L., Van de Ruit, M., Nijweide, P., Papapoulos, S., and Lowik, C. 1993. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture. J. Bone Miner. Res. 8: 263-270.
108. Walker, D.G. 1973. Osteopetrosis in mice cured by temporary parabiosis. Science (Washington, D.C.), 190: 784-785.
109. Walker, D.G. 1975. Bone resorption restored in osteopetrotic mice by transplants odf normal bone marrow and spleen cells. Science (Washington, D.C.), 190: 784-785.
110. Wang, S., and Speck, N.A. 1992. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12: 89-102.
111. Wang, Z.-Q., Ovitt, C., Grigoriadis, A.E., Mohle-Steinlein, U., Ruther, U., and Wagner, E.F. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature (London), 360: 741-745.
112. Ware, C.B., Horowitz, M.C., Renshaw, B.R., Hunt, J.S., Liggitt, D., Koblar, S.A., Gliniak, B.C., McKenna, H.J., Papayannopoulou, T., Thoma, B., Cheng, L., Donovan, P.J., Peschon, J.J., Bartlet, P.F., Willis, C.R., Wright, B.D., Carpenter, M.K., Davison, B.L., and Gearing, D.P. 1995. Target disruption of low-affinity leukemia inhibitory factor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development (Cambridge), 121: 1283-1299.
113. Watanabe, T., Yamaguchi, K., Takatsuki, K., Osame, M., and Yoshida, M. 1990. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type I (HTLV-I) carries and adult T cell leukemia patients that can be trans-activated by HTLV-I tax gene. J. Exp. Med. 172: 759-764.
114. Weilbaecher, K.N., Hershey, C.L., Takemoto, C.M., Horsmann, M.A., Hemesath, T.J., Tashijian, Jr. A.H., and Fisher, D.E. 1998. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187: 775-785.
115. Wiktor-Jedrzejczak, W., Ahmed, A., Szczylik, C., and Skelly, R.R. 1982. Hematological characterization of congenital osteopetrosis in op/op mouse. J. Exp. Med. 156: 1516-1527.
116. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A.W. Jr., Ahmed-Ansari, A., Sell, K.W., Pollard, J.W., and Stanley, E.R. 1990. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U.S.A. 87: 4828-4832.
117. Wong, G.G., Temple, P.A., Leary, A.C., Witek-Giannotti, J.S., Yang, Y.-C., Ciarletta, A.B., Chung, M., Murtha, P., Kriz, R., Kaufman, R.J., Ferenz, C.R., Sibley, B.S., Turner, K.J., Hewick, R.M., Clark, S.C., Yanai, N., Yokota, H., Yamada, M., Saito, M., Motoyoshi, K., and Takaku, F. 1987. Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science (Washington, D.C.), 235: 1504-1508.
118. Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F.S. III, Frankel, W.N., Lee, S.Y., and Choi, Y. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25 190-25 194.
119. Yamane, T., Kunisada, T., Yamazaki, H., Era, T., Nakano, T., and Hayashi, S.I. 1997. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms, but not c-kit dependent. Blood, 90: 3516-3523.
120. Yamazaki, H., Ikeda, H., Ishizu, A., Nakamaru, Y., Sugaya, T., Kikuchi, K., Yamada, S., Wakisaka, A., Kasai, N., Koike, T., Hatanaka, M., and Yoshiki, T. 1997. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I. Int. Immunol. 9: 339-346.
121. Yamazaki, H., Kunisada, T., Ishizu, A., Ikeda, H., Miyoshi, I., Sudo, T., Hayashi, S.I., and Yoshiki, T. 1998. Promotion of early osteoclastogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I. Oncogene, 17: 2955-2960.
122. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. 1998a. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95: 3597-3602.
123. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Morinaga, T., and Higashio, K. 1998b. Identity of osteoclastgenesis inhibitory factor (OCIF) and osteoprogerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology (Baltimore), 13: 1329-1337.
124. Yoshida, H., Hayashi, S.I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L.D., and Nishikawa, S.I. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (London), 345: 442-444.
125. Zhang, D.-E., Hetherington, C.J., Chen, H.-M., and Tenen, D.G. 1994. The macrophage transcriptional factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14: 373-381.